332
Participants
Start Date
June 10, 2022
Primary Completion Date
January 31, 2027
Study Completion Date
June 30, 2027
Domvanalimab
Administered as specified in the treatment arm
Quemliclustat
Administered as specified in the treatment arm
Zimberelimab
Administered as specified in the treatment arm
Fluorouracil
Administered as specified in the treatment arm
Leucovorin
Administered as specified in the treatment arm
Oxaliplatin
Administered as specified in the treatment arm
Columbia University, New York
Virginia Cancer Specialists, Fairfax
Duke University, Durham
Mayo Clinic - Jacksonville, Jacksonville
Florida Cancer Specialist - North, St. Petersburg
Florida Cancer Specialist - South, Fort Myers
SCRI Tennessee Oncology - Nashville, Nashville
Vanderbilt-Ingram Cancer Center, Nashville
Zangmeister Cancer Center, Columbus
OU - Stephenson Cancer Center, Oklahoma City
Mayo Clinic - Arizona, Phoenix
Ronald Reagan UCLA Medical Center, Santa Monica
USC/Norris Comprehensive Cancer Center, Los Angeles
Yale Cancer Center, Derby
Massachusetts General Hospital, Boston
Memorial Sloan Kettering Cancer Center, New York
UHN - Princess Margaret Cancer Centre, Toronto
Clínica San Carlos de Apoquindo, Las Condes
Bradford Hill Centro de Investigaciones Clinicas, Recoleta
Centro de Estudios Clínicos SAGA, Santiago
Clínica Universidad Católica del Maule, Talca
Institut Bergonié _ Bordeaux, Bordeaux
CHU de Brest_Brest, Brest
Centre Baclesse - CAEN, Caen
Centre Oscar Lambret _ LILLE, Lille
Centre Léon Bérard _ Lyon, Lyon
Hôpital Timone - Marseille, Marseille
Institut de Recherche en Cancerologie de Montpellier, Montpellier
Centre Armoricain de Radiothérapie, d'Imagerie Médicale et d'Oncologie, Plérin
Pôle Régional de Cancérologie - Service d'Oncologie Médicale - Poitiers, Poitiers
CHU de Toulouse_Oncopole, Toulouse
Gustave Roussy - Villejuif, Villejuif
MSB - Medicinski Sistem Beograd, Belgrade
University Clinical Center of Serbia, Belgrade
University Hospital Medical Center (KBC) Bezanijska Kosa, Belgrade
Institute of Oncology of Vojvodina, Kamenitz
Clinical Center Kragujevac, Kragujevac
Dong-A University Hospital, Busan
Kyungpook National University Chilgok Hospital, Daegu
Chonnam National University Hwasun Hospital, Hwasun
CHA Bundang Medical Center, Seongnam-si
Asan Medical Center Hospital, Seoul
Korea University Anam Hospital, Seoul
Korea University Guro Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital Cancer Center, Seoul
Ajou University Hospital, Suwon
St. Vincent's Hospital, The Catholic University of Korea, Suwon
Lead Sponsor
Collaborators (1)
Gilead Sciences
INDUSTRY
Arcus Biosciences, Inc.
INDUSTRY